Product Details
Product Name:
Sacituzumab |
CAS No.:
1796566-95-4 |
Purity:
94.6% (SEC-HPLC) |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | Sacituzumab |
Description | Sacituzumab is a humanized IgG1 monoclonal antibody utilized in the synthesis of antibody-active small-molecule couplings (naked antibody to Sacituzumab govitecan). It exhibits potential antitumor activity and is employed in tumor research. |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Keywords | Sacituzumab (antiTrop2) | Sacituzumab (anti Trop 2) | Research Grade Sacituzumab(DHC43301) | anti-Trop-2 |
Inhibitors Related | Belantamab | Naratuximab | Trastuzumab | Daratumumab | Datopotamab | Enfortumab | Inebilizumab | Lonigutamab | Polatuzumab | lorvotuzumab | Disitamab | Glembatumumab |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:99592-32-2
$53.00 / 5mg
-
CAS:178064-13-6
$235.00 / 10mg
-
CAS:193527-91-2
$38.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$455.00/1mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |